The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Open accessAbstract
Objective— Whereas the anti–inflammatory effects of high-density lipoprotein (HDL) on endothelial cells are well described, such effects on monocytes are less studied. Methods and Results— Human monocytes were isolated from whole blood followed by assessment of CD11b activation/expression and cell adhesion under shear-flow. HDL caused a dose-dependent reduction in the activation of CD11b induced by PMA or receptor-dependent agonists. The constituent of HDL responsible for the antiinflammatory effects on CD11b activation was found to be apolipoprotein A-I (apoA-I). Cyclodextrin, but not cyclodextrin/cholesterol complex, also inhibited PMA-induced CD11b activation implicating cholesterol efflux as the main mechanism. This was further confirmed with the demonstration that cholesterol content of lipid rafts diminished after treatment with the cholesterol acceptors. Blocking ABCA1 with an anti-ABCA1 antibody abolished the effect of apoA-I. Furthermore, monocytes derived from a Tangier disease patient definitively confirmed the requirement of ABCA1 in apoA-I–mediated CD11b inhibition. The antiinflammatory effects of apoA-I were also observed in functional models including cell adhesion to an endothelial cell monolayer, monocytic spreading under shear flow, and transmigration. Conclusions— HDL and apoA-I exhibit an antiinflammatory effect on human monocytes by inhibiting activation of CD11b. ApoA-I acts through ABCA1, whereas HDL may act through several receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Cellular Cholesterol Efflux Mediated by Cyclodextrins
Kilsdonk, E. P. C., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17250 · Cited by 890
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
Diamond, M. S., Staunton, D. E., de Fougerolles, A. R., Stacker, S. A., Garcia-Aguilar, J., Hibbs, M. L., & Springer, T. A. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.3129 · Cited by 880
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Diamond, M. S., Staunton, D. E., Marlin, S. D., & Springer, T. A. (1991) · Cell · doi:10.1016/0092-8674(91)90548-d · Cited by 772
Use of cyclodextrins for manipulating cellular cholesterol content
Christian, A. E., Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34940-3 · Cited by 754
Yuhanna, I. S., Zhu, Y., Cox, B. E., Hahner, L. D., Osborne-Lawrence, S., Lu, P., Marcel, Y. L., Anderson, R. G. W., Mendelsohn, M. E., Hobbs, H. H., et al. (2001) · Nature Medicine · doi:10.1038/89986 · Cited by 742
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Nofer, J.-R., van der Giet, M., Tölle, M., Wolinska, I., von Wnuck Lipinski, K., Baba, H. A., Tietge, U. J., Gödecke, A., Ishii, I., Kleuser, B., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18004 · Cited by 698
Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
Kastelein, J. J. P., van Leuven, S. I., Burgess, L., Evans, G. W., Kuivenhoven, J. A., Barter, P. J., Revkin, J. H., Grobbee, D. E., Riley, W. A., Shear, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071359 · Cited by 658
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
Rahaman, S. O., Lennon, D. J., Febbraio, M., Podrez, E. A., Hazen, S. L., & Silverstein, R. L. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.007 · Cited by 506
Matz, C. E., & Jonas, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34756-2 · Cited by 440
Leavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion
Lawrence, M., McIntire, L., & Eskin, S. (1987) · Blood · doi:10.1182/blood.v70.5.1284.1284 · Cited by 373
Nicholls, S. J., Dusting, G. J., Cutri, B., Bao, S., Drummond, G. R., Rye, K.-A., & Barter, P. J. (2005) · Circulation · doi:10.1161/01.cir.0000159351.95399.50 · Cited by 295
Defined Apolipoprotein A-I Conformations in Reconstituted High Density Lipoprotein Discs
Jonas, A., Kézdy, K. E., & Wald, J. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83664-x · Cited by 223
Remaley, A. T., Schumacher, U. K., Stonik, J. A., Farsi, B. D., Nazih, H., & Brewer, H. B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1813 · Cited by 204
Self-citationRemaley, A. T., Thomas, F., Stonik, J. A., Demosky, S. J., Bark, S. E., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Patterson, A. P., Eggerman, T. L., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200475-jlr200 · Cited by 195
Self-citationHigh-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity
Wadham, C., Albanese, N., Roberts, J., Wang, L., Bagley, C. J., Gamble, J. R., Rye, K.-A., Barter, P. J., Vadas, M. A., & Xia, P. (2004) · Circulation · doi:10.1161/01.cir.0000127419.45975.26 · Cited by 162
Badolato, R., Sozzani, S., Malacarne, F., Bresciani, S., Fiorini, M., Borsatti, A., Albertini, A., Mantovani, A., Ugazio, A. G., & Notarangelo, L. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.1026 · Cited by 154
Lynn, W. A., Raetz, C. R., Qureshi, N., & Golenbock, D. T. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3072 · Cited by 145
Gaus, K., Kritharides, L., Schmitz, G., Boettcher, A., Drobnik, W., Langmann, T., Quinn, C. M., Death, A. K., Dean, R. T., & Jessup, W. (2004) · The FASEB Journal · doi:10.1096/fj.03-0486fje · Cited by 116
Duong, M., Collins, H. L., Jin, W., Zanotti, I., Favari, E., & Rothblat, G. H. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000203515.25574.19 · Cited by 105
Woollard, K. J., PHILLIPS, D. C., & Griffiths, H. R. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01978.x · Cited by 99
Self-citationApolipoprotein A-I decreases neutrophil degranulation and superoxide production.
Wd, B., Dohlman, J. G., Venkatachalapathi, Y. V., Pillion, D. J., Koopman, W., Segrest, J., & Anantharamaiah, G. M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41894-2 · Cited by 98
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo
Puranik, R., Bao, S., Nobécourt, E., Nicholls, S. J., Dusting, G. J., Barter, P. J., Celermajer, D. S., & Rye, K.-A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.008 · Cited by 90
Tang, C., Vaughan, A. M., Anantharamaiah, G. M., & Oram, J. F. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500240-jlr200 · Cited by 83
Kimura, T., Tomura, H., Mogi, C., Kuwabara, A., Ishiwara, M., Shibasawa, K., Sato, K., Ohwada, S., Im, D., Kurose, H., et al. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.011 · Cited by 77
Neutrophils activation can be diminished by apolipoprotein A-I
Liao, X., Lou, B., Ma, J., & Wu, M.-P. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.066 · Cited by 75
Arakawa, R., Hayashi, M., Remaley, A. T., Brewer, B., Yamauchi, Y., & Yokoyama, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300553200 · Cited by 74
Self-citationDiederich, W., Orsó, E., Drobnik, W., & Schmitz, G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00518-4 · Cited by 74
Nofer, J., Geigenmüller, S., Göpfert, C., Assmann, G., Buddecke, E., & Schmidt, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.126 · Cited by 68
Nagao, K., Takahashi, K., Hanada, K., Kioka, N., Matsuo, M., & Ueda, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611230200 · Cited by 66
Maier, J. A. M., Barenghi, L., PAGANI, F., Bradamante, S., Comi, P., & Ragnotti, G. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18712.x · Cited by 63
Woollard, K. J., Kling, D., Kulkarni, S., Dart, A. M., Jackson, S. P., & Chin-Dusting, J. P. F. (2005) · Circulation Research · doi:10.1161/01.res.0000199295.14073.69 · Cited by 59
Self-citationMoudry, R., Spycher, M. O., & Doran, J. E. (1997) · Shock · doi:10.1097/00024382-199703000-00004 · Cited by 51
Sviridov, D., Fidge, N., Beaumier-Gallon, G., & Fielding, C. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580079 · Cited by 47
Self-citationCapo, C., Meconi, S., Sanguedolce, M. V., Bardin, N., Flatau, G., Boquet, P., & Mège, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4301 · Cited by 43
Kopprasch, S., Pietzsch, J., & Graessler, J. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000012842.19059.c5 · Cited by 40
Sviridov, D., & Fidge, N. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41107-1 · Cited by 32
Self-citationThe Role of Different Regions of ATP-Binding Cassette Transporter A1 in Cholesterol Efflux
Mukhamedova, N., Fu, Y., Bukrinsky, M., Remaley, A. T., & Sviridov, D. (2007) · Biochemistry · doi:10.1021/bi700473t · Cited by 24
Self-citationPalazón, C. P., Alfon, J. A., Gaffney, P. J., Berrozpe, M., Royo, T., & Badimón, L. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00236-0 · Cited by 24
Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia
Slatter, T. L., Williams, M. J. A., Frikke‐Schmidt, R., Tybjærg‐Hansen, A., Morison, I. M., & McCormick, S. P. A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.019 · Cited by 19
Self-citation
Cited by
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Yvan-Charvet, L., Wang, N., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179283 · Cited by 680
Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
Nagareddy, P. R., Murphy, A. J., Stirzaker, R. A., Hu, Y., Yu, S., Miller, R. G., Ramkhelawon, B., Distel, E., Westerterp, M., Huang, L.-S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.001 · Cited by 577
Self-citationMurphy, A. J., Akhtari, M., Tolani, S., Pagler, T., Bijl, N., Kuo, C.-L., Wang, M., Sanson, M., Abramowicz, S., Welch, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57559 · Cited by 521
Self-citation
Metadata
- Authors
- Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2008-11
- Volume
- 28
- Issue
- 11
- Pages
- 2071-2077
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2107088295
- Cited by
- 508
- References
- 48
- FWCI
- 24.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.